Gregory Alan Korbel - Feb 25, 2022 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
SVP, Chief Business Officer
Signature
/s/ Scott M. Coiante, attorney-in-fact
Stock symbol
APRE
Transactions as of
Feb 25, 2022
Transactions value $
-$2,307
Form type
4
Date filed
3/1/2022, 04:02 PM
Previous filing
Dec 3, 2021
Next filing
Mar 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APRE Common Stock Tax liability -$2.31K -1.33K -7.72% $1.74 15.8K Feb 25, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 3,333 restricted stock units.